4basebio PLC (88Q.DE)

EUR 14.6

(0.0%)

Total Debt Summary of 4basebio PLC

  • 4basebio PLC's latest annual total debt in 2023 was 10.45 Million GBP , up 212.15% from previous year.
  • 4basebio PLC's latest quarterly total debt in 2023 FY was 10.45 Million GBP , up 212.15% from previous quarter.
  • 4basebio PLC reported annual total debt of 3.35 Million GBP in 2022, up 90.56% from previous year.
  • 4basebio PLC reported annual total debt of 1.75 Million GBP in 2021, up 2.39% from previous year.
  • 4basebio PLC reported quarterly total debt of 10.45 Million GBP for 2023 FY, up 212.15% from previous quarter.
  • 4basebio PLC reported quarterly total debt of - GBP for 2023 Q2, down -100.0% from previous quarter.

Annual Total Debt Chart of 4basebio PLC (2023 - 2019)

Historical Annual Total Debt of 4basebio PLC (2023 - 2019)

Year Total Debt Total Debt Growth
2023 10.45 Million GBP 212.15%
2022 3.35 Million GBP 90.56%
2021 1.75 Million GBP 2.39%
2020 1.71 Million GBP -33.66%
2019 2.58 Million GBP 0.0%

Peer Total Debt Comparison of 4basebio PLC

Name Total Debt Total Debt Difference
BioNTech SE 219.1 Million EUR 95.227%
CureVac N.V. 41.85 Million EUR 75.018%
Biotest Aktiengesellschaft 689.8 Million EUR 98.484%
Biotest Aktiengesellschaft 689.8 Million EUR 98.484%
BRAIN Biotech AG 4.65 Million EUR -124.447%
Formycon AG 29.48 Million EUR 64.536%
Heidelberg Pharma AG 5.83 Million EUR -79.323%
Medigene AG 2.95 Million EUR -254.475%